Suppr超能文献

低密度脂蛋白受体第一个富含半胱氨酸重复序列的缺失会损害其在家族性高胆固醇血症患者成纤维细胞中的转运,但不影响脂蛋白结合。

Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.

作者信息

Leitersdorf E, Hobbs H H, Fourie A M, Jacobs M, van der Westhuyzen D R, Coetzee G A

机构信息

Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas 75235.

出版信息

Proc Natl Acad Sci U S A. 1988 Nov;85(21):7912-6. doi: 10.1073/pnas.85.21.7912.

Abstract

The ligand-binding domain of the low density lipoprotein (LDL) receptor is composed of seven cysteine-rich repeats, each approximately 40 amino acids long. Previous studies by van Driel et al. [van Driel, I. R., Goldstein, J. L., Sudhof, T. C. & Brown, M. S. (1987) J. Biol. Chem. 262, 17443-17449] showed that if the first repeat of the ligand-binding domain (encoded by exon 2) is deleted, the receptor fails to bind an anti-LDL receptor monoclonal antibody (IgG-C7) but continues to bind LDL with high affinity. Cultured fibroblasts from a Black South African Xhosa patient (TT) with the clinical syndrome of homozygous familial hypercholesterolemia demonstrated high-affinity cell-surface binding of 125I-labeled LDL but not 125I-labeled IgG-C7. Previous haplotype analysis, using 10 restriction fragment length polymorphic sites, suggested that the patient inherited two identical LDL receptor alleles. The polymerase chain reaction technique was used to selectively amplify exon 2 of the LDL receptor gene from this patient. Sequence analysis of the amplified fragment disclosed a deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat. The mutation creates a new PstI restriction site that can be used to detect the deletion. The existence of this mutant allele confirms that the epitope of IgG-C7 is located in the first cysteine-rich repeat and that this repeat is not necessary for LDL binding. The mutant gene produced a normally sized 120-kilodalton LDL receptor precursor protein that matured to the 160-kilodalton form at less than one-fourth the normal rate. Thus, deletion of two amino acids within the first cysteine-rich repeat retards receptor transport from the endoplasmic reticulum to the cell surface, in contrast to deletion of the entire first repeat, which has no effect on receptor maturation.

摘要

低密度脂蛋白(LDL)受体的配体结合结构域由七个富含半胱氨酸的重复序列组成,每个重复序列约含40个氨基酸。van Driel等人此前的研究[van Driel, I. R., Goldstein, J. L., Sudhof, T. C. & Brown, M. S. (1987) J. Biol. Chem. 262, 17443 - 17449]表明,如果删除配体结合结构域的第一个重复序列(由外显子2编码),该受体无法结合抗LDL受体单克隆抗体(IgG-C7),但仍能以高亲和力结合LDL。一名患有纯合子家族性高胆固醇血症临床综合征的南非科萨族黑人患者(TT)的培养成纤维细胞显示,其细胞表面对125I标记的LDL具有高亲和力结合,但对125I标记的IgG-C7无结合。此前使用10个限制性片段长度多态性位点进行的单倍型分析表明,该患者遗传了两个相同的LDL受体等位基因。采用聚合酶链反应技术从该患者中选择性扩增LDL受体基因的外显子2。对扩增片段的序列分析揭示了六个碱基对的缺失,这导致从第一个富含半胱氨酸的配体结合重复序列中去除了两个氨基酸,即天冬氨酸和甘氨酸。该突变产生了一个新的PstI限制性酶切位点,可用于检测该缺失。这个突变等位基因的存在证实了IgG-C7的表位位于第一个富含半胱氨酸的重复序列中,且该重复序列对于LDL结合并非必需。突变基因产生了一个正常大小的120千道尔顿的LDL受体前体蛋白,但其成熟为160千道尔顿形式的速率不到正常速率的四分之一。因此,与删除整个第一个重复序列(对受体成熟无影响)相反,在第一个富含半胱氨酸的重复序列中删除两个氨基酸会延迟受体从内质网向细胞表面的转运。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f75f/282319/09d8a3f5fe6d/pnas00300-0093-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验